Fremont, Calif. -- ARYx Therapeutics, a Fremont-based biopharmaceutical firm, said on Thursday that it has raised $21.6 million in a private placement, led by new investor New Enterprise Associates (NEA). Previous investors MPM Capital and OrbiMed Advisors also participated in the deal, which includes the sale of more than $9.6 million shares. ARYx focuses on developing products designed to eliminate known safety issues associated with well-established, commercially successful drugs. The firm currently has four products in clinical trials.
http://www.aryx.com
http://biz.yahoo.com/bw/081112/20081112005533.html?.v=1
Listings
Notices
Recent Posts
- San Jose-Based Adobe Systems Acquires Behance
- Santa Clara-Based Coherent Acquires Germany's Lumera Laser
- Gangnam Style Becomes First Video to Hit 1 Billion Views on YouTube
- Redwood Shores-Based Oracle to Acquire Eloqua for $871 Million
- Palo Alto-Based Pluribus Networks Raises $23 Million in Third Round
- Foxconn Acquires $200 Million Stake in San Mateo-Based GoPro
- Palo Alto-Based LUMO BodyTech Raises $5 Million in First Round
- Palo Alto-Based Signifyd Lands $2 Million in Seed Funding
- San Francisco-Based FitStar Raises $1M for Health and Fitness Platform
- National Geographic Suspending New Posts on Instagram
Editor: Rich Scherr
For news tips and editorial issues,
contact editor Rich Scherr at
rich@techwiremedia.com
For advertising information, contract
Parul Nath at parul@techwiremedia.com
A Service of Tech Wire Media
Archives
- December 16, 2012 - December 22, 2012
- December 9, 2012 - December 15, 2012
- December 2, 2012 - December 8, 2012
- November 25, 2012 - December 1, 2012
- November 18, 2012 - November 24, 2012
- November 11, 2012 - November 17, 2012
- November 4, 2012 - November 10, 2012
- October 28, 2012 - November 3, 2012
- October 21, 2012 - October 27, 2012
- October 14, 2012 - October 20, 2012
